Skip to main content
. 2018 Mar 26;70(4):1111–1120. doi: 10.1007/s10616-017-0174-4

Fig. 1.

Fig. 1

Results of trypan blue cell viability assay using a B16F10 and b B16BL6 cells (from left to right: negative control, after treatment with 5 and 10 μg/ml of friedelane and cisplatin (10 µg/ml). Cell viability decreased with increasing concentration of friedelane. ***p < 0.001; **p < 0.01; *p < 0.05. Fr Friedelane